Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity

Area of Science:

• Biochemistry
• Pharmacology
• Biotechnology

Background:

• Superoxide dismutase (SOD) is crucial for neutralizing harmful superoxide radicals.
• Enhancing SOD's cell membrane affinity may improve its therapeutic efficacy.
• Current SOD formulations may have limitations in sustained activity.

Purpose of the Study:

• To investigate if lecithinized superoxide dismutase (PC-SOD) increases pharmacologic potency via enhanced cell membrane affinity.
• To compare the efficacy of PC-SOD with unmodified SOD and polyethylene glycol-bound SOD (PEG-SOD).

Main Methods:

• PC-SOD was synthesized by covalently binding phosphatidylcholine derivatives to recombinant human CuZn-SOD.
• Cell membrane affinity was assessed using laser confocal imaging.
• Superoxide anion scavenging activity was measured in phorbol myristate acetate (PMA)-stimulated human neutrophils.
• In vitro protection against neutrophil-induced endothelial cell damage was evaluated.
• In vivo efficacy was assessed using an ischemia-reperfusion paw edema mouse model.

Main Results:

• PC-SOD exhibited high cell membrane affinity.
• PC-SOD efficiently scavenged superoxide anions from stimulated neutrophils, showing sustained activity even after washing.
• Unmodified SOD and PEG-SOD lacked significant scavenging effects on washed neutrophils.
• PC-SOD provided strong protection against endothelial cell damage, being approximately 100-fold more potent than unmodified SOD.
• PC-SOD significantly inhibited ischemia-reperfusion paw edema in mice, unlike unmodified SOD or PEG-SOD.

Conclusions:

• PC-SOD's enhanced cell membrane affinity significantly increases its pharmacologic activity compared to unmodified SOD.
• PC-SOD demonstrates superior efficacy in scavenging superoxide radicals and protecting against oxidative stress.
• PC-SOD holds potential for various clinical applications requiring effective antioxidant therapy.